Now that COVID-19 vaccine distribution is well underway, pharma and biotech companies are applying lessons learned from the pandemic to the clinical supply chain and new technology solutions. Pharmaceutical industry leaders are examining what they have learned, and whether they can apply key takeaways from the unprecedented COVID response to other therapeutics. In all of this, technology is key. The pandemic proved that healthcare is increasingly dependent on technology, which will only continue as time marches forward.
Three specialists—spanning a biopharmaceutical data strategist, a technology solutions partner, and a supply chain manager for a pharmaceutical company—recently met at the Global Clinical Supplies Group (GCSG) 2021 US Virtual Conference, held April 26-29, 2021. The panelists include:
- Ashish Honawar, Data Strategy Business Lead, Pfizer
- Andrea Ruosi, CEO and Founder, AX for Pharma 365
- Manav Gautam, Manager, Clinical Supply Chain Systems and Analytics, Eli Lilly and Company
This white paper shares highlights of the discussion, lessons learned from the pandemic response and key takeaways as the panelists identified new technological trends for future implementation in the clinical supply chain.
